Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

Similar articles for PubMed (Select 23183092)

1.

Th2-Th1 shift with the multiantigenic formulation TERAVAC-HIV-1 in Balb/c mice.

García-Díaz D, Rodríguez I, Santisteban Y, Márquez G, Terrero Y, Brown E, Iglesias E.

Immunol Lett. 2013 Jan;149(1-2):77-84. doi: 10.1016/j.imlet.2012.11.007. Epub 2012 Nov 24.

PMID:
23183092
2.
3.

Anti-HIV-1 and anti-HBV immune responses in mice after parenteral and nasal co-administration of a multiantigenic formulation.

Iglesias E, García D, Carrazana Y, Aguilar JC, Sánchez A, Gorobaya L, Blanco A.

Curr HIV Res. 2008 Sep;6(5):452-60.

PMID:
18855656
4.

Two mucosal-parenteral schedules to coadminister a multiantigenic formulation against HIV-1 in Balb/c mice.

Iglesias E, García D, Márquez G, Prieto YC, Sánchez J, Trimiño L, Soria Y, García D.

Int Immunopharmacol. 2012 Mar;12(3):487-93. doi: 10.1016/j.intimp.2011.12.026. Epub 2012 Jan 10.

PMID:
22240123
5.

Modulation of Th1/Th2 immune responses to HIV-1 Tat by new pro-GSH molecules.

Fraternale A, Paoletti MF, Dominici S, Buondelmonte C, Caputo A, Castaldello A, Tripiciano A, Cafaro A, Palamara AT, Sgarbanti R, Garaci E, Ensoli B, Magnani M.

Vaccine. 2011 Sep 16;29(40):6823-9. doi: 10.1016/j.vaccine.2011.07.101. Epub 2011 Aug 2.

PMID:
21816192
6.

Potent cross-reactive immune response against the wild-type and drug-resistant forms of HIV reverse transcriptase after the chimeric gene immunization.

Starodubova E, Boberg A, Ivanov A, Latyshev O, Petrakova N, Kuzmenko Y, Litvina M, Chernousov A, Kochetkov S, Karpov V, Wahren B, Isaguliants MG.

Vaccine. 2010 Feb 23;28(8):1975-86. doi: 10.1016/j.vaccine.2009.10.098.

PMID:
20188253
7.

The hepatitis B virus core and e antigens elicit different Th cell subsets: antigen structure can affect Th cell phenotype.

Milich DR, Schödel F, Hughes JL, Jones JE, Peterson DL.

J Virol. 1997 Mar;71(3):2192-201.

8.

Efficient mucosal delivery of the HIV-1 Tat protein using the synthetic lipopeptide MALP-2 as adjuvant.

Borsutzky S, Fiorelli V, Ebensen T, Tripiciano A, Rharbaoui F, Scoglio A, Link C, Nappi F, Morr M, Buttó S, Cafaro A, Mühlradt PF, Ensoli B, Guzmán CA.

Eur J Immunol. 2003 Jun;33(6):1548-56.

PMID:
12778472
9.

Poly(I:C)/alum mixed adjuvant priming enhances HBV subunit vaccine-induced immunity in mice when combined with recombinant adenoviral-based HBV vaccine boosting.

Chuai X, Chen H, Wang W, Deng Y, Wen B, Ruan L, Tan W.

PLoS One. 2013;8(1):e54126. doi: 10.1371/journal.pone.0054126. Epub 2013 Jan 15.

10.

Intranasal immunization with HIV reverse transcriptase: effect of dose in the induction of helper T cell type 1 and 2 immunity.

Pacheco SE, Gibbs RA, Ansari-Lari A, Rogers P.

AIDS Res Hum Retroviruses. 2000 Dec 10;16(18):2009-17.

PMID:
11153084
12.

Evaluation of recombinant Onchocerca volvulus activation associated protein-1 (ASP-1) as a potent Th1-biased adjuvant with a panel of protein or peptide-based antigens and commercial inactivated vaccines.

Xiao W, Du L, Liang C, Guan J, Jiang S, Lustigman S, He Y, Zhou Y.

Vaccine. 2008 Sep 15;26(39):5022-9. doi: 10.1016/j.vaccine.2008.07.028. Epub 2008 Aug 19.

13.

Adsorption to aluminum hydroxide promotes the activity of IL-12 as an adjuvant for antibody as well as type 1 cytokine responses to HIV-1 gp120.

Jankovic D, Caspar P, Zweig M, Garcia-Moll M, Showalter SD, Vogel FR, Sher A.

J Immunol. 1997 Sep 1;159(5):2409-17.

PMID:
9278332
15.
17.

DNA immunization with fusion of CTLA-4 to hepatitis B virus (HBV) core protein enhanced Th2 type responses and cleared HBV with an accelerated kinetic.

Yin Y, Wu C, Song J, Wang J, Zhang E, Liu H, Yang D, Chen X, Lu M, Xu Y.

PLoS One. 2011;6(7):e22524. doi: 10.1371/journal.pone.0022524. Epub 2011 Jul 22.

18.

HIV mucosal vaccine: nasal immunization with gp160-encapsulated hemagglutinating virus of Japan-liposome induces antigen-specific CTLs and neutralizing antibody responses.

Sakaue G, Hiroi T, Nakagawa Y, Someya K, Iwatani K, Sawa Y, Takahashi H, Honda M, Kunisawa J, Kiyono H.

J Immunol. 2003 Jan 1;170(1):495-502.

19.

Influence of aluminum-based adjuvant on the immune response to multiantigenic formulation.

Iglesias E, Franch O, Carrazana Y, Lobaina Y, García D, Sanchez J, García J, Urquiza D, Muzio V, Guillén G, Aguilar JC.

Viral Immunol. 2006 Winter;19(4):712-21.

PMID:
17201666
20.

Cynomolgus macaques immunized with two HIV-1 Tat stabilized proteins raise strong and long-lasting immune responses with a pattern of Th1/Th2 response differing from that in mice.

Turbant S, Martinon F, Moine G, Le Grand R, Léonetti M.

Vaccine. 2009 Aug 27;27(39):5349-56. doi: 10.1016/j.vaccine.2009.06.083. Epub 2009 Jul 14.

PMID:
19607953
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk